Sherbrooke Park Advisers LLC Ionis Pharmaceuticals Inc Transaction History

Sherbrooke Park Advisers LLC

  • $436 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$42.03 - $53.55 $139,959 - $178,321
3,330 Added 49.05%
10,119 $439 Million
Q4 2023

Feb 14, 2024
BUY
$43.39 - $51.63 $80,314 - $95,567
1,851 Added 37.48%
6,789 $343 Million
Q3 2023

Nov 14, 2023
BUY
$38.5 - $47.13 $190,113 - $232,727
4,938 New
4,938 $224 Million
Q4 2022

Feb 14, 2023
BUY
$37.12 - $46.52 $259,839 - $325,640
7,000 New
7,000 $264 Million

Others Institutions Holding IONS

# of Institutions
403
Shares Held
136M
Call Options Held
862K
Put Options Held
582K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Sherbrooke Park Advisers LLC Portfolio

Follow Sherbrooke Park Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sherbrooke Park Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sherbrooke Park Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email